IRIS
SQUADRITO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.155
EU - Europa 4.712
AS - Asia 2.046
SA - Sud America 1.398
AF - Africa 81
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.401
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.065
IE - Irlanda 1.362
BR - Brasile 1.282
SE - Svezia 1.183
CN - Cina 869
SG - Singapore 811
IT - Italia 616
DE - Germania 411
UA - Ucraina 391
FI - Finlandia 209
GB - Regno Unito 123
PL - Polonia 103
IN - India 89
FR - Francia 65
BE - Belgio 55
HK - Hong Kong 53
RU - Federazione Russa 45
CA - Canada 40
AR - Argentina 38
AT - Austria 36
TR - Turchia 31
EE - Estonia 29
BD - Bangladesh 26
EC - Ecuador 24
ZA - Sudafrica 22
NL - Olanda 21
IQ - Iraq 20
MA - Marocco 19
MX - Messico 19
UZ - Uzbekistan 19
ID - Indonesia 18
CZ - Repubblica Ceca 13
CO - Colombia 12
VE - Venezuela 12
IL - Israele 11
IR - Iran 11
PK - Pakistan 11
ES - Italia 10
KE - Kenya 10
AZ - Azerbaigian 9
CL - Cile 9
VN - Vietnam 9
EG - Egitto 8
JO - Giordania 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
HN - Honduras 7
JM - Giamaica 6
LB - Libano 6
PA - Panama 6
TN - Tunisia 6
AL - Albania 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
KG - Kirghizistan 5
KZ - Kazakistan 5
LV - Lettonia 5
NP - Nepal 5
OM - Oman 5
PE - Perù 5
BO - Bolivia 4
CH - Svizzera 4
LT - Lituania 4
PT - Portogallo 4
UY - Uruguay 4
BG - Bulgaria 3
GR - Grecia 3
KH - Cambogia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
RO - Romania 3
SN - Senegal 3
AO - Angola 2
AU - Australia 2
BH - Bahrain 2
EU - Europa 2
JP - Giappone 2
NO - Norvegia 2
PS - Palestinian Territory 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CY - Cipro 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
MT - Malta 1
MY - Malesia 1
NA - Namibia 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.399
Salva come PNG Salva come JPEG
Città #
Dublin 1.362
Chandler 958
Jacksonville 803
Nyköping 654
Singapore 523
Ashburn 476
Beijing 308
Messina 237
Princeton 201
Medford 189
Ann Arbor 163
Cambridge 150
Des Moines 150
Boardman 123
Warsaw 102
Dearborn 96
São Paulo 95
The Dalles 93
New York 79
Woodbridge 66
Wilmington 62
Jinan 58
Nuremberg 58
Brussels 55
Los Angeles 55
Helsinki 54
Hong Kong 53
Munich 46
Rome 46
Shenyang 44
Nanjing 42
Hebei 40
Rio de Janeiro 40
Belo Horizonte 39
Hyderabad 38
Pune 37
San Mateo 37
Ottawa 36
Bremen 34
Houston 33
Haikou 32
Lancaster 29
Brasília 28
Guangzhou 27
Ningbo 26
Seattle 26
Tianjin 26
Zhengzhou 25
Vienna 23
Porto Alegre 22
Hangzhou 21
Nanchang 21
Rosolini 21
Catania 20
Düsseldorf 18
Taizhou 18
Jakarta 17
Campinas 16
Curitiba 15
Tashkent 15
Auburn Hills 14
Guarulhos 14
Changsha 13
Frankfurt am Main 13
Goiânia 13
Sorocaba 13
Baghdad 12
Fuzhou 12
Lanzhou 11
Portsmouth 11
Ardabil 10
Dhaka 10
Hefei 10
Istanbul 10
Milan 10
Norwalk 10
Praia Grande 10
Washington 10
Avola 9
Baku 9
Madrid 9
Osasco 9
Tappahannock 9
Uberlândia 9
Augusta 8
Betim 8
Brno 8
Campo Grande 8
Dong Ket 8
Falls Church 8
Fortaleza 8
Lappeenranta 8
Nairobi 8
Quito 8
Ribeirão Preto 8
Salvador 8
São José dos Campos 8
Amman 7
Amsterdam 7
Cape Town 7
Totale 8.566
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 285
Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis. 148
Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis 132
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 130
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 118
Atrial fibrillation in patients with cirrhosis 115
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappa B activation, blunts TNF-alpha production, and protects against splanchnic artery occlusion shock 108
Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension 106
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 105
Valutazione elastografica (fibroscan) del fegato nelle pazienti con sindrome di Turner 102
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 101
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 99
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 98
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 97
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 97
Acute liver damage following intravenous glucocorticoid treatment for Graves’ ophthalmopathy 96
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 93
17 beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat 92
Inhibition of nuclear factor-kappa B activation by IRFI 042, protects against endotoxin-induced shock 91
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 91
Abnormal left ventricular global strain during exercise-test in young healthy smokers 89
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 87
Antioxidant activity of U-83836E, a second generation lazaroid, during myocardial ischemia/reperfusion injury 87
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 86
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 85
Expression and change of mirs 145, 221 and 222 in hypertensive subjects treated with enalapril, losartan or olmesartan 85
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 84
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 84
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 84
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 83
Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant. 81
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 80
Clinical virology of hepatitis B virus infection 80
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 80
Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury 79
Effects of cloricromene on the levels of endothelin and on the microcirculatory function in peripheral atherosclerotic arteriopathies 79
Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury 79
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 79
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 79
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two–Lipid Center Real-World Experience 79
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 79
G-619, A DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE A(2) RECEPTOR ANTAGONIST, INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA BIOSYNTHESIS 78
Cardiovascular effects of raloxifene hydrochloride 78
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 78
HCV NS5A mutations and response of chronic hepatitis to alpha interferon. 77
The reduction of myocardial damage and leukocyte polymorphonuclear accumulation following coronary artery occlusion by the tyrosine kinase inhibitor tyrphostin AG 556 77
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 77
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 76
Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock 76
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 76
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 76
ANTIBODIES AGAINST INTERCELLULAR-ADHESION MOLECULE-1 PROTECT AGAINST MYOCARDIAL ISCHEMIA-REPERFUSION INJURY IN RAT 75
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 75
Cyclosporin-A reduces leukocyte accumulation and protects against myocardial ischaemia reperfusion injury in rats. 74
Effect of beta blockade on the erythrocyte transport of Na+: evaluation during stimulation by cold pressure test in patients with essential hypertension] 74
Effect of sulfatide on acute lung injury during endotoxemia in rats 74
Fibroscan: a new non invasive method for cross-sectional and longitudinal evaluation of liver dysfunction in Turner syndrome 74
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 74
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 74
Nutraceuticals: A New Challenge against Cadmium‐Induced Testicular Injury 74
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 73
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 73
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 73
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 72
CENTRAL DIPSOGENIC EFFECT OF SYNTHETIC RAT ATRIAL NATRIURETIC POLYPEPTIDE IN NORMOTENSIVE RATS 72
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 72
Recombinant human granulocyte colony-stimulating factor reverts vascular dysfunction 71
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 71
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 71
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 71
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 71
null 70
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 70
Endotoxin tolerance impairs a pertussis-toxin-sensitive G- protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats 70
Evaluation of liver stiffness using transient elastography (fibroscan) in young adults with Turner syndrome. 70
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 70
Hepatitis C virus genome complexity correlates with response to interferon therapy: A study in French patients with chronic hepatitis C 69
The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock 69
Efferent vagal fibre stimulation blunts nuclear factor-kappa B activation and protects against hypovolemic hemorrhagic shock 69
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 69
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 69
Evidence for a role of nuclear factor-kappa B in acute hypovolemic hemorrhagic shock 68
Beneficial effect of raxofelast, an hydrophilic vitamin E analogue, in the rat heart after ischemia and reperfusion injury 68
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 68
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 68
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 68
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 67
Inhibition of tumour necrosis factor and reversal of endotoxin- induced shock by U-83836E, a 'second generation' lazaroid in rats 67
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 67
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 67
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 66
PARTICIPATION OF TUMOR-NECROSIS-FACTOR AND NITRIC-OXIDE IN THE MEDIATION OF VASCULAR DYSFUNCTION IN SPLANCHNIC ARTERY- OCCLUSION SHOCK 66
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 66
Use of a balanced dual cyclooxygenase-1/2 and 5-lypoxygenase inhibitor in experimental colitis 66
Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices 66
Management of High Cardiovascular Risk in Diabetic Patients: Focus on Low Density Lipoprotein Cholesterol and Appropriate Drug Use in General Practice 66
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection 65
Inhibition of lipid peroxidation reduces the inflammatory response and increases early-immediate genes expression in carbon tetrachloride-induced rat liver injuri. 65
Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. 65
Gene transfer of I kappa B alpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury 65
Totale 8.218
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.120
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020503 0 0 0 0 0 0 0 0 0 262 220 21
2020/20211.301 146 16 351 56 69 130 31 144 93 124 94 47
2021/20221.482 25 168 36 42 97 7 99 59 29 297 171 452
2022/20233.905 286 386 164 281 286 403 62 230 1.605 26 132 44
2023/20241.271 76 138 62 121 82 221 14 272 4 86 76 119
2024/20253.526 107 60 80 278 210 180 220 983 1.123 285 0 0
Totale 13.819